New RNA therapy offers hope for mental health

Scientists at Cognigenics have made a significant advance in the field of neuroscience and mental health treatment. Their groundbreaking research, published in Genomic Psychiatry, demonstrates that a new RNA-based therapy called COG-201 can enhance memory and reduce anxiety in animal models.

Iodine-Based Skin Prep Better for Certain Fracture Surgeries

Iodine-based skin antisepsis appeared better for surgical repair of closed limb fractures but on par with chlorhexidine-based antisepsis when the fracture broke the skin, the

February 1, 2024

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment | Psychedelic Invest

Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Mindful Health Solutions (MHS),

May 3, 2024

Competitor manufacturers could benefit from Novo’s acquisition of Catalent, Siegfried CEO says

Pharma companies could turn away from Catalent on the back of its $16.5 billion acquisition by Novo Holdings, which would allow for future opportunities for

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.